Inflation, Supply Chain Headaches And Staffing Shortages: CEOs Talk About 'Big Picture' Challenges

15 Aug 2022

Although procedure volumes have mostly recovered from the shock of COVID-19 two years ago, the effects of the pandemic on the medtech sector and the economy overall will be felt for years to come. In recent analyst and sales and earnings presentations, CEOs of major medtech companies faced questions about how their company is handling these major "macro" issues.

vector cartoon economic vision shutterstock 2156175731 — • Source: Shutterstock

During their recent presentations for analysts and investors, the CEOs of Abbott, Johnson & Johnson, Medtronic, Edwards Lifesciences, Stryker and Zimmer Biomet each discussed the major "headwinds" their companies are facing at this unprecedented moment in history. In Vivo compiled some of the highlights.

Robert Ford